From theinquirer.net
JAPANESE FIRM Terumo claimed that artificial blood it developed won't pass on viral or bacterial infections.
So said Nihon Keizai Shimbun , reporting on the claims.
Not only is the artificial blood sterilised during its manufacture, but Terumo claims it uses so-called artificial red blood cells to be carriers for oxygen.
Clinical tests on humanoids are set to start this time next year and alleviate the worldwide blood shortage.
More details here. Subscription is required. ยต
L'INQ
Terumo English language page
Comments